CS445488A1 - Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment - Google Patents
Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment Download PDFInfo
- Publication number
- CS445488A1 CS445488A1 CS884454A CS445488A CS445488A1 CS 445488 A1 CS445488 A1 CS 445488A1 CS 884454 A CS884454 A CS 884454A CS 445488 A CS445488 A CS 445488A CS 445488 A1 CS445488 A1 CS 445488A1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- treatment
- diseases
- osteo
- disorders
- physiopathological
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 10
- 206010061291 Mineral deficiency Diseases 0.000 title claims abstract description 5
- 201000010099 disease Diseases 0.000 title claims description 6
- 206010061762 Chondropathy Diseases 0.000 title claims description 4
- 208000020084 Bone disease Diseases 0.000 title claims description 3
- 208000035475 disorder Diseases 0.000 title claims description 3
- 238000002360 preparation method Methods 0.000 title abstract description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 230000000035 biogenic effect Effects 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 208000015100 cartilage disease Diseases 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- COESIDLMALPYNV-UHFFFAOYSA-L [O-]C([O-])=O.[Mg+2].P Chemical class [O-]C([O-])=O.[Mg+2].P COESIDLMALPYNV-UHFFFAOYSA-L 0.000 claims description 2
- 238000003801 milling Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 7
- 210000003278 egg shell Anatomy 0.000 abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 4
- 102000002322 Egg Proteins Human genes 0.000 abstract description 3
- 108010000912 Egg Proteins Proteins 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 239000011257 shell material Substances 0.000 abstract description 2
- 210000005067 joint tissue Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000002994 raw material Substances 0.000 description 6
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 201000008482 osteoarthritis Diseases 0.000 description 4
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 210000000991 chicken egg Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000007353 Hip Osteoarthritis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS884454A CS445488A1 (en) | 1988-06-24 | 1988-06-24 | Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment |
| SU894614479A RU1783984C (ru) | 1988-06-24 | 1989-06-21 | Способ получени средства дл компенсации недостатка минеральных солей в организме |
| AT89111364T ATE127020T1 (de) | 1988-06-24 | 1989-06-22 | Pharmazeutische zusammensetzungen mit eierschalenbestandteilen und ihre herstellung und verwendung. |
| DE68924006T DE68924006T2 (de) | 1988-06-24 | 1989-06-22 | Pharmazeutische Zusammensetzungen mit Eierschalenbestandteilen und ihre Herstellung und Verwendung. |
| EP89111364A EP0347899B1 (de) | 1988-06-24 | 1989-06-22 | Pharmazeutische Zusammensetzungen mit Eierschalenbestandteilen und ihre Herstellung und Verwendung |
| JP1159792A JPH0256434A (ja) | 1988-06-24 | 1989-06-23 | 医薬目的のために卵殻から化合物を調製するための方法及び該方法により調製された化合物 |
| US07/371,427 US5045323A (en) | 1988-06-24 | 1989-06-26 | Compound and method of preparing compound for medical purposes from eggshells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS884454A CS445488A1 (en) | 1988-06-24 | 1988-06-24 | Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS445488A1 true CS445488A1 (en) | 1991-01-15 |
Family
ID=5387317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS884454A CS445488A1 (en) | 1988-06-24 | 1988-06-24 | Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5045323A (de) |
| EP (1) | EP0347899B1 (de) |
| JP (1) | JPH0256434A (de) |
| AT (1) | ATE127020T1 (de) |
| CS (1) | CS445488A1 (de) |
| DE (1) | DE68924006T2 (de) |
| RU (1) | RU1783984C (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS445488A1 (en) * | 1988-06-24 | 1991-01-15 | Karol Mvdr Michalek | Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment |
| JPH0592122U (ja) * | 1992-05-11 | 1993-12-14 | 株式会社クラウン・パッケージ | 段ボ−ル製トレ− |
| US6344217B1 (en) | 1994-06-28 | 2002-02-05 | Aar Pharma Adler Apotheke | Putamen OVI |
| DE4422613A1 (de) * | 1994-06-28 | 1996-01-04 | Aar Pharma Adler Apotheke | Putamen ovi |
| DE19751681A1 (de) * | 1997-11-21 | 1999-07-29 | Michael O Ruepp Aar Pharma | Verwendung von Putamen ovi |
| NL9401958A (nl) * | 1994-11-23 | 1996-07-01 | Friesland Brands Bv | Met eierschalenmeel verrijkt melkprodukt. |
| NL1002400C2 (nl) * | 1996-02-20 | 1997-08-21 | Friesland Brands Bv | Oraal calcitonine-preparaat en werkwijze voor het winnen van calcitonine. |
| FR2746652B1 (fr) * | 1996-03-28 | 1998-05-15 | Dupoirieux Laurent Pierre | Utilisation de la coquille d'oeuf comme implant osseux et son mode de fabrication |
| NO303819B1 (no) * | 1996-11-20 | 1998-09-07 | Drymed As | Anvendelse av t°rkede, fertiliserte h°nse-egg for fremstilling av anti-depressive midler |
| IL131927A (en) | 1997-03-18 | 2003-03-12 | Penn State Res Found | Waste egg shell components recovery |
| US7007806B2 (en) * | 1997-03-18 | 2006-03-07 | The Penn State Research Foundation | Method and apparatus for separating a protein membrane and shell material in waste egg shells |
| US5716649A (en) * | 1997-03-20 | 1998-02-10 | Nam; Wal Hee | Process of increasing calcium content in an aqueous solution |
| US8859010B2 (en) * | 2003-05-29 | 2014-10-14 | Biosynergy, Inc. | Method of producing eggshell powder |
| RU2264221C1 (ru) * | 2004-02-24 | 2005-11-20 | Федеральное государственное образовательное учреждение высшего профессионального образования Ставропольский государственный аграрный университет | Способ приготовления комплексного иммунного модулятора |
| NL1031399C2 (nl) * | 2006-03-17 | 2007-09-18 | Biohorma B V | Samenstelling voor het voorkomen, verminderen of behandelen van verlies van botdichtheid. |
| CA2730664A1 (en) * | 2008-07-10 | 2010-01-14 | Ilan Elias | Methods of use of eggshell polypeptides |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558771A (en) * | 1968-02-12 | 1971-01-26 | Leslie L Balassa | Process for using eggshell compositions for promoting wound healing |
| CS445488A1 (en) * | 1988-06-24 | 1991-01-15 | Karol Mvdr Michalek | Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment |
-
1988
- 1988-06-24 CS CS884454A patent/CS445488A1/cs unknown
-
1989
- 1989-06-21 RU SU894614479A patent/RU1783984C/ru active
- 1989-06-22 DE DE68924006T patent/DE68924006T2/de not_active Expired - Fee Related
- 1989-06-22 AT AT89111364T patent/ATE127020T1/de not_active IP Right Cessation
- 1989-06-22 EP EP89111364A patent/EP0347899B1/de not_active Expired - Lifetime
- 1989-06-23 JP JP1159792A patent/JPH0256434A/ja active Pending
- 1989-06-26 US US07/371,427 patent/US5045323A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE68924006T2 (de) | 1996-01-25 |
| EP0347899A2 (de) | 1989-12-27 |
| EP0347899A3 (en) | 1990-03-28 |
| ATE127020T1 (de) | 1995-09-15 |
| RU1783984C (ru) | 1992-12-23 |
| JPH0256434A (ja) | 1990-02-26 |
| DE68924006D1 (de) | 1995-10-05 |
| EP0347899B1 (de) | 1995-08-30 |
| US5045323A (en) | 1991-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS445488A1 (en) | Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment | |
| CN1026064C (zh) | 活性氧抑制组合物的制造方法 | |
| CN1835766B (zh) | 骨生成促进剂 | |
| JP2007504182A (ja) | 骨の治癒を促進するための組成物および方法 | |
| JP4369969B2 (ja) | 生体適合性材料並びにその製造方法 | |
| CN104162150A (zh) | 一种具有增加骨密度功能的组合物及其制备方法 | |
| KR20120028108A (ko) | 미네랄을 함유한 규소 수 제조 및 그 이용방법 | |
| CN106213492A (zh) | 一种提升运动机能并增加骨密度的健康产品及制备方法 | |
| CN104605226A (zh) | 一种具有增加骨密度功能的保健品 | |
| TWI586362B (zh) | 新穎蛋白質素材 | |
| US6344217B1 (en) | Putamen OVI | |
| Hussein et al. | The impact of natural calcium carbonate and Ubiquinone on bone mineral density in rabbits | |
| CN1771051A (zh) | 皮肤胶原产生促进剂 | |
| RU2145228C1 (ru) | Профилактическое и общеукрепляющее средство широкого спектра действия | |
| RU2013133998A (ru) | Способы и композиции для предотвращения и лечения остеоартрита | |
| KR101790031B1 (ko) | 인삼 추출물, 작약 추출물, 감초 추출물 및 키토산을 유효성분으로 포함하는 폐경 또는 난소절제로 인한 여성 골다공증 예방 또는 치료용 약학적 조성물 | |
| CN104888192B (zh) | 一种增加骨密度的海参氨糖制剂及其生产方法 | |
| KR20190054544A (ko) | 실크단백질을 포함하는 줄기세포의 뼈분화 촉진 또는 유도용 조성물 | |
| CN111012900B (zh) | 一种具有增加骨密度功能的组合物及其制备方法与应用 | |
| RU2094051C1 (ru) | Лекарственный препарат "пелвит" и способ его изготовления | |
| CN104587456A (zh) | 一种增加骨密度的保健品的制作工艺 | |
| CN115040635B (zh) | 一种用于治疗类风湿关节炎的生物制剂及其制备方法 | |
| CA2192071C (en) | Putamen ovi | |
| CN105169482B (zh) | 一种牙科骨替代材料及其制备方法 | |
| RU2241473C2 (ru) | Гель для профилактики и лечения дегенеративно-дистрофических поражений суставного хряща и межпозвоночных дисков "стопартроз" и способ его получения |